Quotient Limited and Ortho Clinical Diagnostics Settle Arbitration and Sign Binding Letter of Intent Covering Patient Transfusion Diagnostics
September 08, 2020 06:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that the Company and Ortho Clinical Diagnostics...
Bloodworks Northwest Now Tests All Donors for COVID-19 Antibodies Looking for More Qualified Convalescent Plasma Donors
August 27, 2020 08:30 ET
|
Quotient Limited
Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient JERSEY, Channel Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Bloodworks Northwest is now offering all blood...
Quotient Limited to Publish Quarterly Investor Presentation
August 04, 2020 09:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with...
Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update
August 03, 2020 06:00 ET
|
Quotient Limited
Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnosticsTen commercial placements of MosaiQ platform in...
Quotient Announces Equity Awards
July 23, 2020 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced...
Quotient Announces Appointment of Two New Board Members
July 23, 2020 08:15 ET
|
Quotient Limited
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...
Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain
July 20, 2020 06:00 ET
|
Quotient Limited
JERSEY, Channel Islands, July 20, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited to Report First Quarter 2021 Financial Results and Host Conference Call
July 17, 2020 08:00 ET
|
Quotient Limited
JERSEY, Channel Islands, July 17, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter...
Quotient Limited Added to the Russell 2000 and Russell 3000 Indexes
July 01, 2020 08:00 ET
|
Quotient Limited
JERSEY, Channel Islands, July 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...
Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results
June 09, 2020 06:00 ET
|
Quotient Limited
Developed a high performance COVID-19 Antibody TestSeveral customer contracts signed for MosaiQ system and COVID-19 Antibody TestTransfusion Dx Expanded Immunohematology (IH) Field Trials have...